Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05645380
Title Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC (NeoTRACT)
Acronym NeoTRACT
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Kansas Medical Center
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.